ClinicalTrials.Veeva

Menu

Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts

General Electric (GE) logo

General Electric (GE)

Status

Terminated

Conditions

Breast Cancer

Treatments

Device: Automated Whole Breast Ultrasound
Device: Full Field Digital Mammography
Device: Digital Breast Tomosynthesis

Study type

Observational

Funder types

Industry

Identifiers

NCT02042456
124.03-2013-GES-0003

Details and patient eligibility

About

This study is investigating whether automated whole breast ultrasound can improve detection of cancer in breast cancer screening when used as a supplement to mammography or as a supplement to digital breast tomosynthesis

Enrollment

124 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able and willing to provide signed declaration of informed consent or have a legally authorized representative provide signed declaration of informed consent for participation in all study procedures;
  • Women aged ≥18 years at the time of enrollment;*
  • Women with a previous determination of dense breasts determined by mammogram as heterogeneously dense or extremely dense;
  • At moderately increased or high risk (>15% lifetime risk) for breast cancer based on meeting one or more of the ACS criteria 1:

AND Referred for screening mammography

Exclusion criteria

  • Have been screened using any breast imaging technology in <12 months immediately prior to enrollment;
  • Exhibit breast cancer symptoms according to assessment by the subject's health care provider within one year prior to enrollment;
  • Diagnosed with breast cancer, with or without metastasis, within one year prior to enrollment;
  • Are currently pregnant as determined per standard clinical practice at the investigational site;
  • Present with contraindications to any imaging examination required in the study protocol;
  • Have breast implants; OR
  • Are lactating.

Trial design

124 participants in 1 patient group

Main Cohort
Description:
Subjects enrolled in this group will receive a full field digital mammogram, digital breast tomosynthesis exam and an automated whole breast ultrasound exam as part of their visit.
Treatment:
Device: Digital Breast Tomosynthesis
Device: Automated Whole Breast Ultrasound
Device: Full Field Digital Mammography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems